Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel Groups, Multicenter Trial Investigating the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Women Aged 18-34 Years Undergoing Assisted Reproductive Technology
Conditions
Interventions
Follitropin delta
Placebo
Locations
23
United States
Fertility Treatment Center
Tempe, Arizona, United States
HRC Fertility
Encino, California, United States
Center for Advanced Reproductive Services PC
Farmington, Connecticut, United States
Reproductive Associates of Delaware
Newark, Delaware, United States
Women's Medical Research Group, LLC
Clearwater, Florida, United States
Center for Reproductive Medicine
Winter Park, Florida, United States
Start Date
October 26, 2018
Primary Completion Date
November 11, 2020
Completion Date
November 11, 2020
Last Updated
January 18, 2024
NCT07216742
NCT07515118
NCT07542626
NCT07499804
NCT06826365
NCT07340827
Lead Sponsor
Ferring Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions